Key result
Measuring epicardial fat thickness via echocardiography is proposed as a subclinical marker of cardiovascular disease and a potential therapeutic target in patients with psoriasis.
Why the study?
Psoriasis increases the risk of cardiovascular disease, prompting interest in measuring epicardial fat tissue as a subclinical disease marker and potential therapeutic target.
Population
Patients with psoriasis
Design
Review
Authors
Loading...
May support epicardial fat assessment for CVD risk in psoriasis; leaves open its value as therapeutic target.
Echocardiographic measurement of epicardial fat thickness is proposed as a subclinical marker of cardiovascular disease and a potential therapeutic target in patients with psoriasis.
Kamath et al. (2019) conducted a review in Psoriasis. Echocardiographic measurement of epicardial fat thickness was evaluated. Measuring epicardial fat thickness via echocardiography is proposed as a subclinical marker of cardiovascular disease and a potential therapeutic target in patients with psoriasis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: